Zobrazeno 1 - 9
of 9
pro vyhledávání: '"CT, clinical trial"'
Autor:
Pauline Lory, Jeffrey Lombardi, Clémence Lacroix, Paola Sanchez-Pena, Serena Romani, Aurélie Grandvuillemin
Publikováno v:
Therapie
Aims: At the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, there were no clinically-tested medications for the effective treatment of coronavirus disease. In this context, on 5 March 2020, the French Public H
Autor:
Lee W. Jones, Andres Palomo, Bette J. Caan, Tochi M. Okwuosa, Roberta M. Ray, Randi E. Foraker, Electra D. Paskett, Lisa Johnson
Publikováno v:
JACC: CardioOncology
JACC. CardioOncology, Vol 1, Iss 1, Pp 41-50 (2019)
JACC. CardioOncology, Vol 1, Iss 1, Pp 41-50 (2019)
Objectives The purpose of this study was to investigate whether pre-diagnosis exercise reduces the risk of subsequent cardiovascular events (CVEs) in women with primary breast cancer. Background Cardiovascular disease (CVD) is the leading nonmalignan
Autor:
Miguel Viana-Baptista, Mehdi Namdar, Aleš Linhart, João Paulo Oliveira, Maurizio Pieroni, Christoph Wanner, Dominique P. Germain, Albina Nowak, Victor Fomin, Marco Spada, Ana Jovanovic, Bruno Falissard, Ilkka Kantola, Perry M. Elliott, Max J. Hilz, Renzo Mignani
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 19, Iss, Pp-(2019)
Molecular Genetics and Metabolism Reports
Molecular Genetics and Metabolism Reports
Background Enzyme replacement therapy (ERT) with recombinant human α-galactosidase has been available for the treatment of Fabry disease since 2001 in Europe and 2003 in the USA. Treatment outcomes with ERT are dependent on baseline patient characte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4289c82e9582d03c67d4573c96f5914f
https://www.zora.uzh.ch/id/eprint/171593/
https://www.zora.uzh.ch/id/eprint/171593/
Autor:
Qibin Qi, Lawrence S. Phillips, Joseph C. Larson, Lesley F. Tinker, Rhonda M. Cooper-DeHoff, Ross L. Prentice, Cynthia A. Thomson, Masoud Isanejad, Andrea Z. LaCroix, Lihong Qi, Jeannette M. Beasley
Publikováno v:
BRITISH JOURNAL OF NUTRITION
The British journal of nutrition, vol 117, iss 11
Isanejad, M; Lacroix, AZ; Thomson, CA; Tinker, L; Larson, JC; Qi, Q; et al.(2017). Branched-chain amino acid, meat intake and risk of type 2 diabetes in the Women's Health Initiative. British Journal of Nutrition, 117(11), 1523-1530. doi: 10.1017/S0007114517001568. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/5wz164sp
The British journal of nutrition, vol 117, iss 11
Isanejad, M; Lacroix, AZ; Thomson, CA; Tinker, L; Larson, JC; Qi, Q; et al.(2017). Branched-chain amino acid, meat intake and risk of type 2 diabetes in the Women's Health Initiative. British Journal of Nutrition, 117(11), 1523-1530. doi: 10.1017/S0007114517001568. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/5wz164sp
Knowledge regarding association of dietary branched-chain amino acid (BCAA) and type 2 diabetes (T2D), and the contribution of BCAA from meat to the risk of T2D are scarce. We evaluated associations between dietary BCAA intake, meat intake, interacti
Publikováno v:
Vaccine
Highlights • A wide variety of RSV neutralization assay formats are currently used by the field. • This study assessed the current level of agreement between twelve assay formats. • Results showed precision was consistently high, whereas agreem
Publikováno v:
Sondergeld, P, van de Donk, N W C J, Richardson, P G & Plesner, T 2015, ' Monoclonal antibodies in myeloma ', Clinical Advances in Hematology & Oncology, vol. 13, no. 9, pp. 599-609 . < http://www.hematologyandoncology.net/index.php/archives/september-2015/monoclonal-antibodies-in-myeloma/ >
Sondergeld, P, van de Donk, N W C J, Richardson, P G & Plesner, T 2015, ' Monoclonal Antibodies in Myeloma ', Clinical Advances in Hematology & Oncology, vol. 13, no. 9, pp. 599-609 . < http://www.hematologyandoncology.net/files/2015/09/ho0915_sondergeld.pdf >
Clinical Advances in Hematology & Oncology, 13(9), 599-609. Millennium Medical Publishing, Inc.
Scopus-Elsevier
Sondergeld, P, van de Donk, N W C J, Richardson, P G & Plesner, T 2015, ' Monoclonal Antibodies in Myeloma ', Clinical Advances in Hematology & Oncology, vol. 13, no. 9, pp. 599-609 . < http://www.hematologyandoncology.net/files/2015/09/ho0915_sondergeld.pdf >
Clinical Advances in Hematology & Oncology, 13(9), 599-609. Millennium Medical Publishing, Inc.
Scopus-Elsevier
The development of monoclonal antibodies (mAbs) for the treatment of disease goes back to the vision of Paul Ehrlich in the late 19th century; however, the first successful treatment with a mAb was not until 1982, in a lymphoma patient. In multiple m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::558cc95e87290bdcfd3507d285ad35c2
http://www.hematologyandoncology.net/index.php/archives/september-2015/monoclonal-antibodies-in-myeloma/
http://www.hematologyandoncology.net/index.php/archives/september-2015/monoclonal-antibodies-in-myeloma/
Autor:
Okwuosa TM; Rush University Medical Center, Division of Cardiology, Department of Internal Medicine; Chicago, Illinois, USA., Ray RM; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Palomo A; Rush University Medical Center, Department of Internal Medicine, Chicago, Illinois, USA., Foraker RE; Institute for Informatics (I2), Washington University in St. Louis, School of Medicine, St. Louis, Missouri, USA., Johnson L; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Paskett ED; Division of Cancer Prevention and Control, Department of Medicine, College of Medicine, The Ohio State University, Columbus, Ohio, USA., Caan B; Division of Research, Kaiser Permanente of Northern California, Oakland, California, USA., Jones LW; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Publikováno v:
JACC. CardioOncology [JACC CardioOncol] 2019 Sep 24; Vol. 1 (1), pp. 41-50. Date of Electronic Publication: 2019 Sep 24 (Print Publication: 2019).
Autor:
Germain DP; French Referral Center for Fabry disease, Division of Medical Genetics and INSERM U1179, University of Versailles, Paris-Saclay University, Montigny, France., Elliott PM; University College London and Barts Heart Centre, London, United Kingdom., Falissard B; INSERM U1018, University of Paris-Sud, University of Paris-Descartes, Paris, France., Fomin VV; Department of Internal Diseases No.1, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation., Hilz MJ; Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany., Jovanovic A; Mark Holland Metabolic Unit, Salford Royal NHS Foundation Trust, Salford, United Kingdom., Kantola I; Division of Medicine, Turku University Hospital, University of Turku, Turku, Finland., Linhart A; Second Department of Medicine - Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Mignani R; Department of Nephrology, Infermi Hospital, Rimini, Italy., Namdar M; Service de Cardiologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland., Nowak A; Department of Internal Medicine, University Hospital of Zurich and University of Zurich, Zurich, Switzerland., Oliveira JP; Department of Genetics, São João Hospital Centre and Faculty of Medicine and 'Instituto de Investigação e Inovação em Saúde (iS3)', University of Porto, Porto, Portugal., Pieroni M; Cardiovascular Department, San Donato Hospital, Arezzo, Italy., Viana-Baptista M; Serviço de Neurologia, Hospital Egas Moniz, Centro Hospitalar de Lisboa Ocidental; CEDOC Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal., Wanner C; Division of Nephrology, University Clinic, University of Würzburg, Würzburg, Germany., Spada M; Department of Paediatrics, University of Torino, Torino, Italy.
Publikováno v:
Molecular genetics and metabolism reports [Mol Genet Metab Rep] 2019 Feb 06; Vol. 19, pp. 100454. Date of Electronic Publication: 2019 Feb 06 (Print Publication: 2019).
Branched-chain amino acid, meat intake and risk of type 2 diabetes in the Women's Health Initiative.
Autor:
Isanejad M; 1Institute of Public Health and Clinical Nutrition,University of Eastern Finland,Kuopio,Finland., LaCroix AZ; 2Department of Family Medicine and Public Health,University of California San Diego,San Diego, CA,USA., Thomson CA; 3Department of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health,University of Arizona, Tucson,AZ,USA., Tinker L; 4Division of Public Health Sciences,Fred Hutchinson Cancer Research Center,Seattle,WA,USA., Larson JC; 4Division of Public Health Sciences,Fred Hutchinson Cancer Research Center,Seattle,WA,USA., Qi Q; 5Department of Epidemiology and Population Health,Albert Einstein College of Medicine,Bronx,NY,USA., Qi L; 6Department of Public Health Sciences,Division of Biostatistics,University of California, Davis,Davis,CA,USA., Cooper-DeHoff RM; 7Pharmacotherapy and Translational Research,College of Pharmacy, University of Florida,Gainesville,FL,USA., Phillips LS; 8Atlanta VA Medical Center,Decatur,GA,USA., Prentice RL; 4Division of Public Health Sciences,Fred Hutchinson Cancer Research Center,Seattle,WA,USA., Beasley JM; 10Division of General Internal Medicine and Clinical Innovation,New York University School of Medicine,New York,NY,USA.
Publikováno v:
The British journal of nutrition [Br J Nutr] 2017 Jun; Vol. 117 (11), pp. 1523-1530.